| |
|
|
|
KemPharm Inc.  
|
|
1.69 0.01 (0.01%) |
05-23 16:00 |
|
Open: |
1.66 |
Pre close: |
1.625 |
Target:
|
2.04
|
|
High: |
1.7 |
Low: |
1.56 |
Resistance:
|
1.75
2.04
|
|
Volume: |
138,310 |
Market Cap: |
45M |
Support:
|
1.38
1.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.56
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.40 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
2.01  |
Stochastic Oscillator |
%K(14,3):
|
93.74 |
|
MA(250): |
3.30 |
%D(3): |
83.13 |
|
Average Volume(K) |
3-Month: |
21810
|
52-Week |
High:
|
7.15 |
|
10-Days: |
14906 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
62.82 |
Change(%): |
-73.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.160 |
Return on Equity (ttm) |
92.8 |
Shares Out. (M) |
28.52 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-146.7 |
Shares Float (M) |
28.23 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.00 |
|
Forward EPS |
-2.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.53 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.20 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-27.85 |
P/CF |
-0.89 |
|
|
|
|
|
|
